Similar articles for PMID: 36396456

Year	Number of Results
2013	1
2014	1
2015	3
2016	9
2017	9
2018	14
2019	18
2020	21
2021	23
2022	22
2023	17
2024	1

1

A Pilot Study of ⁶⁸Ga-PSMA11 and ⁶⁸Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer.

Duan H, Ghanouni P, Daniel B, Rosenberg J, Thong A, Kunder C, Aparici CM, Davidzon GA, Moradi F, Sonn GA, Iagaru A. Duan H, et al. J Nucl Med. 2023 May;64(5):744-750. doi: 10.2967/jnumed.122.264448. Epub 2022 Nov 17. J Nucl Med. 2023. PMID: 36396456 Free PMC article.

2

A Pilot Study of ⁶⁸Ga-PSMA11 and ⁶⁸Ga-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High-Intensity Focused Ultrasound Therapy.

Duan H, Ghanouni P, Daniel B, Rosenberg J, Davidzon GA, Aparici CM, Kunder C, Sonn GA, Iagaru A. Duan H, et al. J Nucl Med. 2023 Apr;64(4):592-597. doi: 10.2967/jnumed.122.264783. Epub 2022 Nov 3. J Nucl Med. 2023. PMID: 36328488 Free article.

3

Correlation of ⁶⁸Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer.

Duan H, Baratto L, Fan RE, Soerensen SJC, Liang T, Chung BI, Thong AEC, Gill H, Kunder C, Stoyanova T, Rusu M, Loening AM, Ghanouni P, Davidzon GA, Moradi F, Sonn GA, Iagaru A. Duan H, et al. J Nucl Med. 2022 Dec;63(12):1829-1835. doi: 10.2967/jnumed.122.263971. Epub 2022 May 12. J Nucl Med. 2022. PMID: 35552245 Free article.

4

Prospective Evaluation of ⁶⁸Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging.

Minamimoto R, Sonni I, Hancock S, Vasanawala S, Loening A, Gambhir SS, Iagaru A. Minamimoto R, et al. J Nucl Med. 2018 May;59(5):803-808. doi: 10.2967/jnumed.117.197624. Epub 2017 Oct 30. J Nucl Med. 2018. PMID: 29084827 Free article.

5

PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.

Baratto L, Song H, Duan H, Hatami N, Bagshaw HP, Buyyounouski M, Hancock S, Shah S, Srinivas S, Swift P, Moradi F, Davidzon G, Iagaru A. Baratto L, et al. J Nucl Med. 2021 Nov;62(11):1545-1549. doi: 10.2967/jnumed.120.259630. Epub 2021 Mar 5. J Nucl Med. 2021. PMID: 33674398 Free PMC article.

6

Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.

Touijer KA, Michaud L, Alvarez HAV, Gopalan A, Kossatz S, Gonen M, Beattie B, Sandler I, Lyaschenko S, Eastham JA, Scardino PT, Hricak H, Weber WA. Touijer KA, et al. Eur Urol Oncol. 2019 Mar;2(2):166-173. doi: 10.1016/j.euo.2018.08.011. Epub 2018 Sep 22. Eur Urol Oncol. 2019. PMID: 31017093 Free PMC article. Clinical Trial.

7

Diagnostic Performance of ⁶⁸Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.

Margel D, Bernstine H, Groshar D, Ber Y, Nezrit O, Segal N, Yakimov M, Baniel J, Domachevsky L. Margel D, et al. Radiology. 2021 Nov;301(2):379-386. doi: 10.1148/radiol.2021204093. Epub 2021 Aug 31. Radiology. 2021. PMID: 34463555

8

Value of ⁶⁸Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [¹⁸F]fluoromethylcholine PET-CT and multiparametric MRI-a phase I/II study.

Beheshti M, Taimen P, Kemppainen J, Jambor I, Müller A, Loidl W, Kähkönen E, Käkelä M, Berndt M, Stephens AW, Minn H, Langsteger W. Beheshti M, et al. Eur Radiol. 2023 Jan;33(1):472-482. doi: 10.1007/s00330-022-08982-2. Epub 2022 Jul 21. Eur Radiol. 2023. PMID: 35864350 Free PMC article. Clinical Trial.

9

[68Ga-PSMA-11 PET/mpMRI for local detection of primary prostate cancer in men with a negative prior biopsy].

Maurer T, Gesterkamp H, Nguyen N, Westenfelder K, Gschwend JE, Budäus L, Rauscher I, Vag T, Weber W, Eiber M. Maurer T, et al. Aktuelle Urol. 2021 Apr;52(2):143-148. doi: 10.1055/a-1198-2305. Epub 2020 Aug 27. Aktuelle Urol. 2021. PMID: 32854128 German.

10

Histological comparison between predictive value of preoperative 3-T multiparametric MRI and ⁶⁸ Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.

Franklin A, Yaxley WJ, Raveenthiran S, Coughlin G, Gianduzzo T, Kua B, McEwan L, Wong D, Delahunt B, Egevad L, Samaratunga H, Brown N, Parkinson R, Roberts MJ, Yaxley JW. Franklin A, et al. BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7. BJU Int. 2021. PMID: 32524748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year